(Q36842733)

16 August 2017

1 reference

title

The molecular basis of antibody-mediated neutralization of West Nile virus (English)

1 reference

16 August 2017

0 references

2

Michael S Diamond

0 references

Theodore Oliphant

series ordinal

1

object named as

Theodore Oliphant

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Expert Opinion on Biological Therapy

16 August 2017

published in

1 reference

16 August 2017

volume

7

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

885-892

1 reference

The outbreak of West Nile virus infection in the New York City area in 1999

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

A Critical Role for Induced IgM in the Protection against West Nile Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Protective immune responses against West Nile virus are primed by distinct complement activation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Complement activation is required for induction of a protective antibody response against West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Role of CD8+ T cells in control of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

A structural perspective of the flavivirus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

A ligand-binding pocket in the dengue virus envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Conformational changes of the flavivirus E glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Structure of the dengue virus envelope protein after membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Visualization of membrane protein domains by cryo-electron microscopy of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Structure of West Nile Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Architecture of the SARS coronavirus prefusion spike

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Structures of immature flavivirus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Characterization of neutralizing antibodies to West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Neutralizing monoclonal antibodies against Russian strain of the West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Localization of a neutralizing epitope on the envelope protein of dengue virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Structural basis of West Nile virus neutralization by a therapeutic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Occupancy and mechanism in antibody-mediated neutralization of animal viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

A new mechanism for the neutralization of enveloped viruses by antiviral antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Alteration of virus entry mode: a neutralisation mechanism for Dengue-2 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virus. Brief report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.885

21 January 2018

Identifiers

DOI

10.1517/14712598.7.6.885

1 reference

release_uvesvhq3xretpputsimixq5isa

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uvesvhq3xretpputsimixq5isa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference